Pharmacyte Biotech, Inc.

PMCB

Financials

10-QQ1 ended 07/31/2609/14/26 10-KFY 202607/29/26 10-QQ3 ended 01/31/2603/17/26 10-QQ2 ended 10/31/2512/18/25 10-QQ1 ended 07/31/2509/15/25

Disclosures

8-KCurrent report10/16/26 8-KCurrent report04/02/26 8-KCurrent report12/05/25 8-K/ACurrent report (amended)11/18/25 8-KCurrent report10/31/25

Prospectuses and Registrations

S-3Shelf registration09/17/25 S-8Registration of securities for employees12/04/24 S-3/AShelf registration (amended)09/21/23 S-3/AShelf registration (amended)09/12/23 S-3/AShelf registration (amended)08/04/23

Proxies

DEF 14ADefinitive proxy03/09/26 PRE 14APreliminary proxy02/27/26 DEF 14ADefinitive proxy10/06/25 PRE 14APreliminary proxy09/24/25 DEF 14ADefinitive proxy03/10/25

Ownership

4/AInsider transaction (amended)07/17/26 4/AInsider transaction (amended)07/17/26 4/AInsider transaction (amended)07/17/26 4/AInsider transaction (amended)07/17/26 Form 4Insider transaction04/02/26

Other

ARSAnnual report to shareholders03/09/26 NT 10-QLate filing notification (10-Q)12/15/25 EFFECTRequest for effectiveness09/26/25 CORRESPCorrespondence with the SEC09/24/25 UPLOADLetter from the SEC09/23/25